<DOC>
	<DOCNO>NCT00932074</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability efficacy KP‑413 topical ointment compare vehicle ointment treat adult subject atopic dermatitis ( AD ) .</brief_summary>
	<brief_title>A Study Determine Safety , Tolerability Efficacy KP‑413 Subjects With Atopic Dermatitis ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Has clear diagnosis AD meeting Hanifin Rajka criterion AD involve head/neck torso/limbs , affect 530 % subject 's total BSA determine use rule nine Has Baseline IGSS 3 ( moderate ) 4 ( severe ) select treatment area torso/limbs , Baseline IGSS 2 ( mild ) , 3 ( moderate ) 4 ( severe ) select treatment area head/neck . Female childbearing potential negative pregnancy test use effective method contraception study . Female pregnant , nursing infant , plan pregnancy study period . Has Baseline oozing/crusting score 3 ( moderate ) great select treatment area head/neck torso/limbs . Presence concurrent skin condition could interfere assessment treatment . Treatment investigational drug device within 30 day 5 half life ( whichever longer ) prior Baseline visit , concurrent participation another clinical trial investigational drug device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Atopic Dermatitis</keyword>
</DOC>